Not Signed In -
Trypanosomiasis, African |
|
|
Clinical Trial: GBR 12909 Study in Cocaine Experienced African American Volunteers - 1
This study is no longer recruiting patients.
Purpose
The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders | Drug: GBR 12909 | Phase I |
MedlinePlus related topics: Cocaine Abuse
Study Type: Interventional
Study Design: Treatment, Placebo Control
Official Title: GBR 12909 Study in Cocaine Experienced African American Volunteers
Expected Total Enrollment: 10
Study start: April 2004; Study completion: May 2005
Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.
Eligibility
Ages Eligible for Study: 18 Years - 45 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Must be within 20% of ideal body weight and must weigh at least 45 kg.
- Must understand the study procedures and provide written informed consent.
- Must meet DSM-4 criteria for abuse or dependence on cocaine.
- Must be non-treatment seeking at the time of the study.
Exclusion Criteria:
- Please contact the study site for more information.
Location Information
Maryland
Uniformed Services University of Health Science, Bethesda, Maryland, 20814 4799, United States
Louis Cantilena, M.D., Principal Investigator, Uniformed Services University of Health Science
More Information
Record last reviewed: January 2005
Last Updated: February 16, 2005
Record first received: August 10, 2004
ClinicalTrials.gov Identifier: NCT00089687
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- African Trypanosomiasis (Centers for Disease Control and Prevention)
email this page
print this page
bookmark this page
feedback on this page
